
Fredric B Kraemer MD
Diabetes, Lipid Metabolism
Professor, Medicine - Endocrinology, Gerontology, & Metabolism, Stanford University
Join to view full profile
300 Pasteur DriveDivision Of Endocrinology, S025Stanford, CA 94305
Phone+1 650-493-5000
Fax+1 650-852-3263
Dr. Kraemer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Fredric Kraemer, MD is a Stanford-based endocrinologist specializing in diabetes and lipid metabolism. He completed his fellowship in Endocrinology, Diabetes, and Metabolism at Stanford University and his residency at SUNY Downstate Health Sciences University following his graduation from New York University School of Medicine in 1974. He has been on the faculty at Stanford University School of Medicine since 1983 and is currently the Gerald M. Reaven MD Professor of Endocrinology, Emeritus, having served as the Chief of the Division of Endocrinology, Gerontology and Metabolism for over 20 years. He was previously a Staff Physician at the VA Palo Alto Health Care System from 1988-2024. His research interests include diabetes mellitus, lipid metabolism disorders, and related cellular processes. Dr. Kraemer has authored over 200 publications in reputable journals and has participated in clinical trials.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1981
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1974 - 1978
New York University School of MedicineClass of 1974
Certifications & Licensure
CA State Medical License 1978 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
Publications & Presentations
PubMed
- Nherf2 is a major determinant of bile acid pool dynamics and contributes to regulation of Western diet-induced obesity.Dachuan Dong, Wen-Jun Shen, Stefanie Bittner, Jia Chen, Xiao Hao
American Journal of Physiology. Cell Physiology. 2025-12-01 - 3 citationsAblation of Steroidogenic Superoxide Dismutase 2 Increases Oxidative Stress and Diminishes Steroid Hormone Production.Wen-Jun Shen, Ting-Ting Huang, Yuan Cortez, Syed Kashif Zaidi, Sara Arshad
Endocrinology. 2025-07-08 - HDL meets triglyceride.Tugce Akcan, Fredric B Kraemer
Journal of Lipid Research. 2025-05-01
Press Mentions
How to Support a Loved One Who Has Been Diagnosed with Type 2 DiabetesAugust 29th, 2019
Bench to Bedside: Translating Science from the Lab to the ClinicMay 2nd, 2019
Grant Support
- LipolysisVeterans Affairs2011–2012
- Mechanisms How Adipocytes Affect Bone In Aging MiceNational Institute On Aging2006–2010
- Mechanisms How Adipocytes Affect Bone In Aging MiceNational Institute On Aging2006
- Regulation Of Hormone Sensitive LipaseNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2003
- Regulation Of Cholesterol Esterase In SteroidogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









